提高白内障围手术期睑缘炎的认识和加强围手术期管理

doi:10.3760/cma.j.cn115909-20201015-00395

摘要
图/表
参考文献(38)
相关文章 (15)

全文: PDF 886KB HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

文章导读

摘要年龄相关性白内障和睑缘炎是老年人高发的疾病，睑缘炎是最常见的眼表疾病。睑缘炎会降低白内障手术的效果，影响患者术后满意度。现从白内障围手术期睑缘炎的评估、治疗以及术中的眼表保护等进行探讨和论述，进一步加深临床医师认识治疗白内障围手术期睑缘炎的重要性。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ： , 白内障手术, 睑缘炎, 围手术期

Abstract： Age-related cataract and blepharitis are the most common diseases in the elderly. Blepharitis can reduce the effect of cataract surgery and affect the postoperative satisfaction of patients. In this paper, we discuss the importance of perioperative blepharitis evaluation and treatment, and intraoperative ocular surface protection. The purpose is to enhance the clinicians' understanding of the importance of blepharitis evaluation and treatment during the cataract perioperative period.

Key words： cataract surgery blepharitis perioperative period

收稿日期: 2020-10-15

PACS:

基金资助:

通讯作者: 赵云娥（ORCID：0000-0003-4401-8053），Email：zyehzeye@126.com

引用本文:

赵银莹傅亚娜赵云娥. 提高白内障围手术期睑缘炎的认识和加强围手术期管理[J]. 中华眼视光学与视觉科学杂志, 2021, 23(7): 481-485. Yinying Zhao, Yana Fu, Yun’e Zhao. To Improve the Understanding and Management of Blepharitis in Cataract Patients during the Perioperative Period. Chinese Journal of Optometry Ophthalmology and Visual science, 2021, 23(7): 481-485. DOI: 10.3760/cma.j.cn115909-20201015-00395

链接本文:

https://www.cjoovs.com/CN/10.3760/cma.j.cn115909-20201015-00395 或 https://www.cjoovs.com/CN/Y2021/V23/I7/481

[1]	Flaxman SR, Bourne R, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990-2020: A systematic review and meta-analysis. Lancet Glob Health, 2017, 5(12): e1221-e1234.
[2]	Gollogly HE, Hodge DO, St Sauver JL, et al. Increasing incidence of cataract surgery: Population-based study. J Cataract Refract Surg, 2013, 39(9): 1383-1389.
[3]	Li XM, Hu L, Hu J, et al. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery. Cornea, 2007, 26(9 Suppl 1): S16-20.
[4]	Oh T, Jung Y, Chang D, et al. Changes in the tear film and ocular surface after cataract surgery. Jpn J Ophthalmol, 2012, 56(2): 113-8.
[5]	Kasetsuwan N, Satitpitakul V, Changul T, et al. Incidence and pattern of dry eye after cataract surgery. PLoS One, 2013, 8(11): e78657.
[6]	Jee D, Park M, Lee HJ, et al. Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome. J Cataract Refract Surg, 2015, 41(4): 756-763.
[7]	McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology, 1982, 89(10): 1173-1180. DOI: 10.1016/s0161-6420(82)34669-2.
[8]	Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf, 2017, 15(3): 334-365.
[9]	Epitropoulos AT, Matossian C, Berdy GJ, et al. Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning. J Cataract Refract Surg, 2015, 41(8): 1672-7.
[10]	Lin X, Wu Y, Chen Y, et al. Characterization of meibomian gland atrophy and the potential risk factors for middle aged to elderly patients with cataracts. Transl Vis Sci Technol, 2020, 9(7): 48. DOI: 10.1167/tvst.9.7.48.
[11]	Cochener B, Cassan A, Omiel L. Prevalence of meibomian gland dysfunction at the time of cataract surgery. J Cataract Refract Surg, 2018, 44(2): 144-148.
[12]	Cronje-Dunn S, Harris WF. Keratometric variation: The influence of a fluid layer. Ophthalmic Physiol Opt, 1996, 16(3): 234-6.
[13]	Suzuki T, Mitsuishi Y, Sano Y, et al. Phlyctenular keratitis associated with meibomitis in young patients. Am J Ophthalmol, 2005, 140(1): 77-82.
[14]	Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol, 1984, 68(8): 524-528.
[15]	Suzuki T. Meibomitis-related keratoconjunctivitis: implications and clinical significance of meibomian gland inflammation. Cornea, 2012, 31 Suppl 1: S41-4.
[16]	Seal DV, McGill JI, Jacobs P, et al. Microbial and immunological investigations of chronic non-ulcerative blepharitis and meibomianitis. Br J Ophthalmol, 1985, 69(8): 604-11.
[17]	Szczotka-Flynn LB, Maguire MG, Ying GS, et al. Impact of dry eye on visual acuity and contrast sensitivity: Dry eye assessmentand management study. Optom Vis Sci, 2019, 96(6): 387-396.
[18]	Schiffman RM, Walt JG, Jacobsen G, et al. Utility assessment among patients with dry eye disease. Ophthalmology, 2003, 110(7): 1412-9.
[19]	Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci, 2003, 44(11): 4753-61.
[20]	Xue W, Zhu MM, Zhu BJ, et al. Long-term impact of dry eye symptoms on vision-related quality of life after phacoemulsification surgery. Int Ophthalmol, 2019, 39(2): 419- 429.
[21]	Han KE, Yoon SC, Ahn JM, et al. Evaluation of dry eye and meibomian gland dysfunction after cataract surgery. Am J Ophthalmol, 2014, 157(6): 1144-1150.e1.
[22]	Miyake K, Yokoi N. Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study. Clin Ophthalmol, 2017, 11: 529-540.
[23]	Gomes J, Azar DT, Baudouin C, et al. TFOS DEWS II iatrogenic report. Ocul Surf, 2017, 15(3): 511-538.
[24]	Yu Y, Hua H, Wu M, et al. Evaluation of dry eye after femtosecond laser-assisted cataract surgery. J Cataract Refract Surg, 2015, 41(12): 2614-23.
[25]	Ju RH, Chen Y, Chen HS, et al. Changes in ocular surface status and dry eye symptoms following femtosecond laser-assisted cataract surgery. Int J Ophthalmol, 2019, 12(7): 1122-1126.
[26]	Jung JW, Han SJ, Nam SM, et al. Meibomian gland dysfunction and tear cytokines after cataract surgery according to preoperative meibomian gland status. Clin Exp Ophthalmol, 2016, 44(7): 555-562.
[27]	Cho YK, Kim MS. Dry eye after cataract surgery and associated intraoperative risk factors. Korean J Ophthalmol, 2009, 23(2): 65-73.
[28]	Ishrat S, Nema N, Chandravanshi S. Incidence and pattern of dry eye after cataract surgery. Saudi J Ophthalmol, 2019, 33(1): 34-40.
[29]	Amescua G, Akpek EK, Farid M, et al. Blepharitis Preferred Practice Pattern® . Ophthalmology, 2019, 126(1): 56-93. DOI: 10.1016/j.ophtha.2018.10.019.
[30]	亚洲干眼协会中国分会, 海峡两岸医药交流协会眼科专业委员会眼表与泪液病学组. 我国蠕形螨睑缘炎诊断和治疗专家共识(2018年). 中华眼科杂志, 2018, 54(7): 491-495. DOI: 10.3760/cma.j.issn.0412-4081.2018.07.004.
[31]	Ge J, Liu N, Wang X, et al. Evaluation of the efficacy of optimal pulsed technology treatment in patients with cataract and Meibomian gland dysfunction in the perioperative period. BMC Ophthalmol, 2020, 20(1): 111.
[32]	Song P, Sun Z, Ren S, et al. Preoperative management of MGD alleviates the aggravation of MGD and dry eye induced by cataract surgery: A prospective, randomized clinical trial. Biomed Res Int, 2019, 2019: 2737968.
[33]	Fogagnolo P, Favuzza E, Marchina D, et al. New therapeutic strategy and innovative lubricating ophthalmic solution in minimizing dry eye disease associated with cataract surgery: A randomized, prospective study. Adv Ther, 2020, 37(4): 1664- 1674.
[34]	俞晓宇, 王丹丹, 常平骏, 等. 角膜保护剂对白内障术后干眼的影响. 中华眼视光学与视觉科学杂志, 2017, 19(4): 236-242.
[35]	Cetinkaya S, Mestan E, Acir NO, et al. The course of dry eye after phacoemulsification surgery. BMC Ophthalmol, 2015, 15(1): 68.
[36]	Labiris G, Ntonti P, Sideroudi H, et al. Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: A comparative study. Eye Vis (Lond), 2017, 4: 13.
[37]	Ntonti P, Panagiotopoulou EK, Karastatiras G, et al. Impact of 0.1% sodium hyaluronate and 0.2% sodium hyaluronate artificial tears on postoperative discomfort following cataract extraction surgery: A comparative study. Eye Vis (Lond), 2019, 6: 6.
[38]	中华医学会眼科学分会白内障与人工晶状体学组. 我国白内障围手术期非感染性炎症反应防治专家共识(2015 年). 中华眼科杂志, 2015, 51(3): 163-166. DOI: 10.3760/cma. j.issn.0412-4081.2015.03.002.